Intravitreal Injections, incl. Lucentis & Avastin
Intravitreal Injections are used to treat Macular Degeneration (MD).
MD refers to a group of degenerative diseases of the retina that cause progressive, painless loss of central vision, affecting the ability to see fine detail, drive, read and recognise faces.Macular Degeneration is the leading cause of blindness and severe vision loss in Australia. One in seven people over the age of 50 are affected by the disease and the incidence increases with age and is often called Age-related Macular Degeneration (AMD).
Treatments for MD?
In the past few years there have been advancements made in slowing down and in some cases even stopping the progression of AMD.
Anti-VEGF drugs such as Lucentis (Ranibizumab) and Avastin are now available to help in the treatment of wet AMD.
Lucentis works by inhibiting the growth of the abnormal blood vessels that cause AMD. It is also used to treat swelling of the macula due to AMD.
The goal of treatment is to prevent further loss of vision. Your doctor will advise you of the treatment that is most suitable for your individual needs.
95% of patients using these drugs maintain their baseline vision and 45% will improve their baseline vision.
Optimum lighting, glasses and sometimes magnifying devices can also greatly assist people with this condition.
Laser treatment is also sometimes indicated for the ‘wet’ form of AMD. There is currently no treatment for Dry MD.